Alembic Pharmaceuticals has reported 30 percent rise in consolidated net profit to Rs 169.83 crore for the quarter ended December 31, 2018 mainly on account of robust sales in the US….Read More
Torrent Pharmaceuticals is selling six brands in cardiac and diabetic therapies as part of a portfolio restructuring following Unichem and Elder Pharma buyouts in recent past. Torrent has mandated investment…Read More
Zydus Cadila has received the final approval from the USFDA to market Triamterene and Hydrochlorothiazide capsules USP (US RLD – DYAZIDE), 37.5 mg/25 mg. It will be manufactured at the…Read More
Glenmark Pharmaceuticals Limited has reported its financial results for the third quarter ended December 31 of the financial year 2018-19. In the third quarter ended December 31, 2018, Glenmark’s consolidated…Read More
The US FDA has issued Form 483 with 11 observations for Dr. Reddy’s Laboratories’ manufacturing facility in Hyderabad. Earlier on April 28, 2017, Dr. Reddy’s Bachupally manufacturing plant had received…Read More
Aurobindo Pharma Ltd. plans to acquire a portfolio of seven branded oncology injectable products from Spectrum Pharmaceuticals Inc. The acquisition involves an upfront payment of USD 160 million in cash,…Read More
The audit of the Dr Reddy’s Laboratories’ formulations Srikakulum Plant (SEZ) Unit I, Andhra Pradesh by the US Food and Drug Administration (USFDA), has been completed. The company has received…Read More
Cadila Pharmaceuticals Ltd. has signed an agreement with Norway-based Inven2’s start-up, SERCA Pharmaceuticals, to develop a new treatment for heart patients. The new drug is based on an invention by…Read More
Glenmark Pharmaceuticals is targeting a consolidated revenue growth of up to 15 percent over the next 3 to 5 years. This would be mainly on account of strengthening the current…Read More
Pfizer Inc. has decided to shut down its manufacturing units in Irungattukottai, Chennai, and Aurangabad, Maharashtra, which came to it through an acquisition of injectables manufacturer Hospira in 2015. While…Read More
Sun Pharma has entered into a definitive agreement to acquire Pola Pharma, which is engaged in research and development, manufacture, sale, and distribution of branded, and generic products in Japan….Read More
Lupin is in the process of developing a pipeline of products under its new drug discovery program to treat various diseases like cancer and metabolic disorders. The company, which last…Read More
Suven Life Sciences has received one product patent from Brazil and one from Eurasia corresponding to the new chemical entities for the treatment of disorders associated with neurodegenerative diseases. These…Read More
Glenmark Pharmaceuticals Limited announced its financial results for the second quarter (2Q) ended September 30 of financial year 2018-19. In the 2Q, Glenmark’s consolidated revenue was at Rs 25,813.32 million as…Read More
Sun Pharmaceutical has entered into a definitive agreement to acquire Pola Pharma Inc., a Japanese pharmaceutical company engaged in research and development, manufacture, sale, and distribution of branded and generic…Read More